Jivora Coxsackievirus A7/B1 IgG-/IgA-antibodies™

Regular price $226.00
Sale price $226.00 Regular price Bundle Price
Unit price
  • SKU:
    JT054
Ask a question

Ask a Question

* Required fields

Size guide Share

Persistent symptoms like fatigue or respiratory discomfort deserve a detailed look. Jivora Coxsackievirus A7/B1 IgG-/IgA-antibodies™ is a professional laboratory screening designed to detect the immune response to two common strains of the Enterovirus family, providing a clearer picture of your immunological history.

What is Coxsackievirus?

Coxsackieviruses are common viruses that thrive in the digestive tract. While many exposures are brief, the immune system creates specific "defense proteins" (antibodies) that provide a record of the body's interaction with the virus. A laboratory screening can help you understand your immune memory regarding these strains.

Why Choose This Screening?

  • Dual-Antibody Mapping: This analysis identifies both IgA (mucosal response) and IgG (long-term memory) antibodies to provide a layered view of your immune status.

  • Standardized Methodology: We utilize the ELISA technique, a widely recognized laboratory process for identifying the body's specific immune response to viral exposure.

  • Expansive Insights: For those investigating lingering immune triggers or establishing a wellness baseline, this screening offers essential data to share with a healthcare professional.


Who It’s For:

  • Wellness Investigators: Individuals seeking to establish an immunological baseline following a period of systemic fatigue or inflammatory distress.

  • Proactive Health Strategists: Those looking to map their immunological history to support long-term wellness goals.

  • Functional Medicine Patients: Individuals working with practitioners to identify potential environmental viral triggers.


About Your Jivora Coxsackievirus A7/B1 IgG-/IgA-antibodies™

Convenient Access to Wellness Insights

You can order your testing kit directly through Jivora Health, an authorized ArminLabs partner. Our streamlined online process respects your privacy and security, allowing you to take a proactive role in monitoring your immune health without the need for a prior office visit.

Simple, Needle-Free Collection at Home

Each kit features the FDA-cleared Tasso+ device, designed for easy and virtually painless blood collection from the upper arm. This innovative technology allows you to collect a high-quality sample without traditional needles. If you prefer, a standard clinical blood draw option is also available. Both methods are validated for sample stability and laboratory accuracy.

Informational Results for Better Conversations

Your report provides a detailed look at how your immune system reacts to specific tick-borne antigens. These findings are educational in nature and intended to help you have more informed discussions with your healthcare provider. Please note that these results are not a medical diagnosis and should not be used as a standalone basis for a treatment plan.

Medications and Testing

While most common medications do not impact the results, certain intensive therapies - such as strong immunosuppressants, chemotherapy, or interferon-gamma therapy - may affect your immune system’s natural reactivity. We recommend consulting your clinician before sample collection if you are currently undergoing these treatments.

Fast, Secure, and Supported

Once your sample is received by the laboratory, your secure digital report is typically available within 7 to 10 business days. To help you navigate your findings, Jivora Health provides access to a complimentary educational review to explain the data markers in your report.

Comprehensive Immune Screening

Traditional screenings often focus on a single strain of Borrelia. The ArminLabs approach provides a broader perspective by screening for reactivity to Borrelia burgdorferi, Borrelia afzelii, and Borrelia garinii. By including persistent-form (round-body) antigens, this test offers a more comprehensive view of your immune profile, reducing the limitations found in narrower testing methods.

Understanding Your Immune Markers

  • IgM Reactivity: Typically associated with a more recent or active immune response.

  • IgG Reactivity: Generally indicates an immune memory or long-term reactivity. ArminLabs calibrates these markers to provide you and your healthcare professional with a clear map of your immune system’s history and current status.

The Science of Antigen Diversity

Borrelia bacteria are known for their ability to shift forms, including "round-body" or pleomorphic states. Because these different forms can trigger different immune responses, our testing includes specific antigens for both active and persistent forms. This multi-antigen approach ensures a more thorough assessment of immune reactivity that standard screenings might overlook.


Regulatory Status: The Tasso+ collection device is FDA-cleared. The laboratory tests provided by ArminLabs are Laboratory Developed Tests (LDTs). These tests have not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary for LDTs when performed by a CLIA-certified laboratory.

Educational Use: These results are for informational purposes only. They are not intended to diagnose, treat, cure, or prevent any disease. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

*This test was developed and its performance characteristics determined by ArminLabs. It has not been cleared or approved by the U.S. Food and Drug Administration. This test is intended for informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Technical Information
key fact
Detection of specific IgG and IgA antibodies against Coxsackievirus (serotypes A7 and B1).
material
ELISA-based test. 1 tube of serum/Z-gel is required.
further information on the test
In the early stage of Coxsackievirus infection, IgA antibodies are found; in the chronic stage, specific IgG antibodies are also present. IgA antibodies are produced by the nasopharyngeal mucous membranes and can persist for months.
further information on the pathogen
Coxsackieviruses are obligate intracellular single-stranded RNA viruses in the Picornaviridae/Enterovirus family, divided into Group A and Group B with corresponding serotypes. Transmission: fecal-oral. Incubation period: 2-10 days.

Coxsackievirus A symptoms: Skin redness, acute fever with throat complaints (herpangina), acute flaccid paralysis, conjunctivitis, carditis, myositis, pancreatitis.

Coxsackievirus B symptoms: Skin redness, acute fever with throat complaints (herpangina), aseptic meningitis, chorioretinitis, carditis, epidemic pleurodynia, fulminant hepatitis, hand-foot-and-mouth disease, meningitis, myocarditis, pericarditis, pleuritis.

Important:These test results are for informational and educational purposes only. They provide immune response markers and are not intended to diagnose, treat, cure, or prevent any disease. This test should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider before making any health-related decisions based on test results.